Literature DB >> 83236

Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells.

L Boumsell, A Bernard, V Lepage, L Degos, J Lemerle, J Dausset.   

Abstract

One set of antigens is common to some chronic lymphocytic leukemia (CLL) cells bearing surface immunoglobulins (Ig) and normal T cells. Proliferating cells from thirty-eight patients were studied with four antisera recognizing normal human T but not B cells. These antisera were raised in rabbits against (a) Sezary cells, (b) blood lymphocytes from a patient with sex-linked agammaglobulinemia, (c) T lymphoblasts and (d) thymus cells. In four CLL cases, the cells expressed the receptor for sheep erythrocytes and lacked surface Ig. Cells from thirty-four CLL cases bore monoclonal surface Ig and did not bind sheep erythrocytes. Twelve out of these thirty-four cases of CLL had cells which were lysed by one or, more frequently, by the four anti-human T cell xenoantisera. By absorption experiments, one set of at least three antigens common to the cells of some of these CLL and T cells was defined. Depending on the patient, the cells can either carry one, some or all of the antigens of this set. However, it was also demonstrated by absorption that these cells lacked antigens particular to the T cell lineage, while the cells from T CLL cases carried both sets of antigens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83236     DOI: 10.1002/eji.1830081214

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures.

Authors:  R Farkas; S Ben-Efraim; Y Manor; I Zan-Bar; A Klajman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.

Authors:  J A Tooze; D H Bevan
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

3.  Phenotype of chronic lymphocytic leukemia (CLL) B-cells. B-CLL cells express the Leu-8 antigen.

Authors:  A Cafaro; M Napolitano; V Zoli; L Pacilli; I Mezzaroma; A De Laurenzi; F Pandolfi
Journal:  Blut       Date:  1987-01

4.  Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL).

Authors:  H V Marquart; K Grønbaek; B E Christensen; S E Svehag; R G Leslie
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

5.  Cell-marker studies in CLL with monoclonal OKT antisera and lactic dehydrogenase isoenzyme analysis.

Authors:  L Sabbe; J Plum; M De Smedt; G Leroux; A Louwagie; A Criel
Journal:  Blut       Date:  1983-05

6.  Crossreaction of monoclonal anti-T-cell antibodies: implications for classifying B-cell leukemias.

Authors:  R Munker; E Thiel; U Kummer; H Rodt; S Thierfelder
Journal:  Blut       Date:  1983-02

7.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.

Authors:  Roberta Bichi; Susan A Shinton; Eric S Martin; Anatoliy Koval; George A Calin; Rossano Cesari; Giandomenico Russo; Richard R Hardy; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Receptors for IgA on a subpopulation of human B lymphocytes.

Authors:  S Gupta; C D Platsoucas; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells.

Authors:  P J Martin; J A Hansen; R C Nowinski; M A Brown
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

10.  Binding of sheep erythrocytes in chronic lymphocytic leukemias of B-cell origin.

Authors:  G Semenzato; G Pizzolo; F Gerosa; F Pandolfi; A Pezzutto; G C Andrighetto; I Quinti; C Agostini; R Foa; G Tridente
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.